Please select the option that best describes you:

What is your current approach to maintenance therapy in FLT3-mutant AML post allogeneic HCT?   

Have you changed your practice given BMT-CTN 1506/Morpho results?

Would you utilize maintenance therapy in patients who achieve MRD- remission?

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist at West Penn Hospital
Hello Dr. @Yared -  I just wanted to clarify ...
Sign in or Register to read more